Furthermore, Tang et al. identified a potential increase in HCC risk associated with CD14 on CD14+ CD16− monocytes, aligning with our findings that CD64 on CD14− CD16+ monocytes is associated with an increased risk of HCC. This evidence concerns the gene FCGR1A and hepatocellular carcinoma.